- Home
- AKRO vs THO Comparison
AKRO vs THO Comparison
Compare AKRO & THO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- THO
- Stock Information
- Founded
- AKRO 2017
- THO 1980
- Country
- AKRO United States
- THO United States
- Employees
- AKRO N/A
- THO N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- THO Homebuilding
- Sector
- AKRO Health Care
- THO Industrials
- Exchange
- AKRO Nasdaq
- THO Nasdaq
- Market Cap
- AKRO 3.9B
- THO 4.0B
- IPO Year
- AKRO 2019
- THO N/A
- Fundamental
- Price
- AKRO $49.65
- THO $81.22
- Analyst Decision
- AKRO Strong Buy
- THO Hold
- Analyst Count
- AKRO 8
- THO 9
- Target Price
- AKRO $82.50
- THO $84.75
- AVG Volume (30 Days)
- AKRO 1.9M
- THO 643.3K
- Earning Date
- AKRO 05-12-2025
- THO 06-04-2025
- Dividend Yield
- AKRO N/A
- THO 2.46%
- EPS Growth
- AKRO N/A
- THO N/A
- EPS
- AKRO N/A
- THO 3.79
- Revenue
- AKRO N/A
- THO $9,496,171,000.00
- Revenue This Year
- AKRO N/A
- THO N/A
- Revenue Next Year
- AKRO N/A
- THO $7.44
- P/E Ratio
- AKRO N/A
- THO $21.41
- Revenue Growth
- AKRO N/A
- THO N/A
- 52 Week Low
- AKRO $17.86
- THO $63.16
- 52 Week High
- AKRO $58.40
- THO $118.85
- Technical
- Relative Strength Index (RSI)
- AKRO 63.34
- THO 56.39
- Support Level
- AKRO $44.94
- THO $77.96
- Resistance Level
- AKRO $49.29
- THO $83.12
- Average True Range (ATR)
- AKRO 3.33
- THO 2.22
- MACD
- AKRO 0.67
- THO 0.04
- Stochastic Oscillator
- AKRO 86.02
- THO 50.08
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About THO Thor Industries Inc.
Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth wheel towables across over 30 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motorcaravans, campervans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts through the acquisition of Airxcel in 2021, however, this is still a nascent part of the business as it accounts for less than 10% of total sales. In fiscal 2023, the company wholesaled 187,015 units and generated over $11.1 billion in revenue.